Pharmacokinetics and haemodynamic effect of deacetyl diltiazem (M1) in rabbits after a single intravenous administration

Biopharmaceutics and Drug Disposition

Volumn 19, Issue 2, 1998, Pages 109-113

  Yeung, Pollen K F ^a   Feng, Joe D Z ^a   Buckley, Susan J ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Diltiazem; Haemodynamics; Metabolism; Pharmacodynamics; Pharmacokinetics

Indexed keywords

CALCIUM ANTAGONIST; DEACETYLDILTIAZEM; DILTIAZEM; DRUG METABOLITE;

ANGINA PECTORIS; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DEACETYLATION; DEAMINATION; DEMETHYLATION; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG ELIMINATION; DRUG METABOLISM; HEART RATE; HEMODYNAMICS; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RABBIT; VASODILATATION;

ANIMALS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIASTOLE; DILTIAZEM; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; INJECTIONS, INTRAVENOUS; RABBITS; SYSTOLE;

EID: 0031942208     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199803)19:2<109::AID-BDD84>3.0.CO;2-V     Document Type: Article

References (25)

1. Medical Letter, Drugs for hypertension. Med. Letter, 35, 55-60 (1993). .
2. Medical Letter, Drugs for stable angina pectoris. Med. Letter, 36, 111-114 (1994).
3. M. Weir, Diltiazem: ten years of clinical experience in the treatment of hypertension. J. Clin. Pharmacol, 35, 220-232 (1995).
4. P.K.F. Yeung, T.J. Montague, B. Tsui and C. McGregor, High performance liquid chromatographic assay in healthy volunteers. J. Pharm. Sci., 78, 592-597 (1989).
5. G. Caille, S. Boucher, J. Spenard, Z. Lakhani, A. Russell, J. Thiffault and M.G. Grace, Diltiazem pharmacokinetics in elderly volunteers after single and multiple doses. Eur. J. Drug. Metab. Pharmacokinet., 16, 75-80 (1991).
6. M. Hussain, Y. Tam, M. Gray and R. Coutts, Mechanism of time-dependent kinetics of diltiazem in the isolated perfused rat liver. Drug Metab. Disposit., 22, 36-42 (1994).
7. P. Yeung, S. Buckley, O. Hung, P. Pollak, K. Barclay, J. Feng, P. Farmer and G. Klassen, Steady-state plasma concentrations of diltiazem and its metabolites in patients and healthy volunteers. Ther. Drug Monit., 18, (1996).
8. E. LeBoeuf and O. Grech-Belanger, Deacetylation of diltiazem by rat liver. Drug Metab. Disposit., 15, 122-126 (1987).
9. P. Yeung, S. Buckley, R. Cameron, J. Feng and J. Jordan, Effect of phenobarbital pre-treatment on the pharmacokinetics and metabolism of diltiazem in rats. Drug Metab. Drug. Interact., 13, 29-39 (1996).
10. H. Yabana, T. Nagao and M. Sato, Cardiovascular effects of the metabolites of diltiazem in dogs. J. Cardiavasc. Pharmacol., 7, 152-157 (1985).
11. A. Kiyomoto, Y. Sasaki, A. Odawara and T. Morita, Inhibition of platelet aggregation by diltiazem. Circ. Res., 52 (Suppl. I), 115-119 (1983).
12. P.K.F. Yeung, S.J. Mosher, D.A. MacRae and G.A. Klassen, Effect of diltiazem and its metabolites on the uptake of adenosine in blood: An in-vitro investigation. J. Pharm. Pharmacol., 43, 685-689 (1991).
13. Y.H. Lee, M.H. Lee and C.K. Shim, Pharmacokinetics of diltiazem and deacetyldiltiazem in rats. Int. J. Pharm., 76, 71-76 (1991).
14. R. Li, P.S. Farmer, M. Xie, M.A, Quilliam, S. Pleasance, S.E. Howlett and P.K.F. Yeung, Synthesis, characterization and calcium antagonistic activity of diltiazem metabolites. J. Med. Chem., 35, 3246-3253 (1992).
15. G. Caille, L.M. Dube, Y. Theoret, F. Varin, N. Mousseau and M.I.J., Stability study of diltiazem and two of its metabolites using a high-performance liquid Chromatographic method. Biopharm. Drug Dispos., 10, 107-114 (1989).
16. A.M. McLean, E.A. Cefali, J.S. Roden, M.A. Gonzalez and M. Bialer, Stability of diltiazem in different biological fluids. Biopharm. Drug Dispos., 12, 327-334.
17. P.K.F. Yeung, S.J. Mosher, G.A. Klassen, and I.J. McGilveray, Stability of diltiazem and its metabolites in plasma during storage. Ther. Drug. Monit., 13, 369-374 (1991).
18. H. Cheng, A method for calculating the mean transit times and distribution rate parameters of metabolites without separate intravenous administration of metabolite. J. Pharm. Sci., 81, 488-490 (1992).
19. M. Gibaldi and D. Perrier, Pharmacokinetics, 2nd edn, Dekker, New York, 1982.
20. J.C. Fleishaker, J.P. Phillips, T.C. Smith and R.B. Smith, Multiple-dose pharmacokinetics and pharmacodynamics of adinazolam in elderly subjects. Pharm. Res., 6, 379-386 (1989).
21. P.K.F. Yeung, S.J. Mosher and P.T. Pollak, Pharmacokinetics and metabolism of diltiazem in rabbits after a single intravenous or single oral administration. Eur. J. Drug. Metab. Pharmacokinet., 16, 69-74 (1991).
22. N. Holford and L. Sheiner, Pharmacokinetic and pharmacodynamic modeling in vivo. CRC Crit. Rev. Bioeng., July, 273-321 (1981).
23. J. Gabrielsson and D. Weiner, Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications, 1st edn, Swedish Pharmaceutical Press, Stockholm, 1994.
24. Y. Sugawara, M. Ohasi, S. Nakamura, S. Usuki, T. Suzuki, Y. Ito, T. Kume, S. Harigaya, A. Nakao, M. Gaino and H. Inoue, Metabolism of diltiazem. I. Structures of new acidic and basic metabolites in rats, dog and man. J. Pharmacobio-Dyn., 11, 211-223 (1988).
25. T. Halbrugge, B. Friedgen, J. Ludwig and K.-H. Graefe, Effects of catechol-O-methyltransferase inhibition on the plasma clearance of noradrenaline and the formation of 3, 4-dihydroxyphenylglycol in the rabbit. Naunyn-Schmiedeberg's Arch. Pharmakol., 347, 162-170 (1993).